Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Index by author

February 01, 2012; Volume 340,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abdiche, Yasmina

    1. You have access
      Proprotein Convertase Substilisin/Kexin Type 9 Antagonism Reduces Low-Density Lipoprotein Cholesterol in Statin-Treated Hypercholesterolemic Nonhuman Primates
      Hong Liang, Javier Chaparro-Riggers, Pavel Strop, Tao Geng, Janette E. Sutton, Daniel Tsai, Lanfang Bai, Yasmina Abdiche, Jeanette Dilley, Jessica Yu, Si Wu, S. Michael Chin, Nicole A. Lee, Andrea Rossi, John C. Lin, Arvind Rajpal, Jaume Pons and David L. Shelton
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 228-236; DOI: https://doi.org/10.1124/jpet.111.187419
  2. Aguayo, Luis G.

    1. You have access
      The Basic Property of Lys385 Is Important for Potentiation of the Human α1 Glycine Receptor by Ethanol
      Patricio A. Castro, Maximiliano Figueroa, Gonzalo E. Yevenes, Loreto S. San Martin and Luis G. Aguayo
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 339-349; DOI: https://doi.org/10.1124/jpet.111.185140
  3. Ali, Akhtar

    1. You have access
      Changes in Mouse Liver Protein Glutathionylation after Acetaminophen Exposure
      Xi Yang, James Greenhaw, Akhtar Ali, Qiang Shi, Dean W. Roberts, Jack A. Hinson, Levan Muskhelishvili, Richard Beger, Lisa M. Pence, Yosuke Ando, Jinchun Sun, Kelly Davis and William F. Salminen
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 360-368; DOI: https://doi.org/10.1124/jpet.111.187948
  4. Allen, Scott C.

    1. You have access
      Methamphetamine Self-Administration Causes Persistent Striatal Dopaminergic Alterations and Mitigates the Deficits Caused by a Subsequent Methamphetamine Exposure
      Lisa M. McFadden, Greg C. Hadlock, Scott C. Allen, Paula L. Vieira-Brock, Kristen A. Stout, Jonathan D. Ellis, Amanda J. Hoonakker, David M. Andrenyak, Shannon M. Nielsen, Diana G. Wilkins, Glen R. Hanson and Annette E. Fleckenstein
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 295-303; DOI: https://doi.org/10.1124/jpet.111.188433
  5. Amalric, Marianne

    1. You have access
      The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease
      Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, Marianne Amalric, Anna L. Blobaum, Thomas M. Bridges, Ryan D. Morrison, Satyawan Jadhav, Darren W. Engers, Kimberly Italiano, Jacob Bode, J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, P. Jeffrey Conn and Colleen M. Niswender
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 404-421; DOI: https://doi.org/10.1124/jpet.111.187443
  6. Ando, Yosuke

    1. You have access
      Changes in Mouse Liver Protein Glutathionylation after Acetaminophen Exposure
      Xi Yang, James Greenhaw, Akhtar Ali, Qiang Shi, Dean W. Roberts, Jack A. Hinson, Levan Muskhelishvili, Richard Beger, Lisa M. Pence, Yosuke Ando, Jinchun Sun, Kelly Davis and William F. Salminen
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 360-368; DOI: https://doi.org/10.1124/jpet.111.187948
  7. Andrenyak, David M.

    1. You have access
      Methamphetamine Self-Administration Causes Persistent Striatal Dopaminergic Alterations and Mitigates the Deficits Caused by a Subsequent Methamphetamine Exposure
      Lisa M. McFadden, Greg C. Hadlock, Scott C. Allen, Paula L. Vieira-Brock, Kristen A. Stout, Jonathan D. Ellis, Amanda J. Hoonakker, David M. Andrenyak, Shannon M. Nielsen, Diana G. Wilkins, Glen R. Hanson and Annette E. Fleckenstein
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 295-303; DOI: https://doi.org/10.1124/jpet.111.188433
  8. Armer, Richard E.

    1. You have access
      Pharmacologic Profile of OC000459, a Potent, Selective, and Orally Active D Prostanoid Receptor 2 Antagonist That Inhibits Mast Cell-Dependent Activation of T Helper 2 Lymphocytes and Eosinophils
      Roy Pettipher, Shân L. Vinall, Luzheng Xue, Graham Speight, Elizabeth R. Townsend, Lucien Gazi, Cliff J. Whelan, Richard E. Armer, Mark A. Payton and Michael G. Hunter
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 473-482; DOI: https://doi.org/10.1124/jpet.111.187203
  9. Aroor, Annayya R.

    1. You have access
      Histone H3 Phosphorylation (Ser10, Ser28) and Phosphoacetylation (K9S10) Are Differentially Associated with Gene Expression in Liver of Rats Treated In Vivo with Acute Ethanol
      Taryn T. James, Annayya R. Aroor, Robert W. Lim and Shivendra D. Shukla
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 237-247; DOI: https://doi.org/10.1124/jpet.111.186775

B

  1. Bai, Lanfang

    1. You have access
      Proprotein Convertase Substilisin/Kexin Type 9 Antagonism Reduces Low-Density Lipoprotein Cholesterol in Statin-Treated Hypercholesterolemic Nonhuman Primates
      Hong Liang, Javier Chaparro-Riggers, Pavel Strop, Tao Geng, Janette E. Sutton, Daniel Tsai, Lanfang Bai, Yasmina Abdiche, Jeanette Dilley, Jessica Yu, Si Wu, S. Michael Chin, Nicole A. Lee, Andrea Rossi, John C. Lin, Arvind Rajpal, Jaume Pons and David L. Shelton
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 228-236; DOI: https://doi.org/10.1124/jpet.111.187419
  2. Bakajsova, Diana

    1. You have access
      γ-Tocotrienol Protects against Mitochondrial Dysfunction and Renal Cell Death
      Grażyna Nowak, Diana Bakajsova, Corey Hayes, Martin Hauer-Jensen and Cesar M. Compadre
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 330-338; DOI: https://doi.org/10.1124/jpet.111.186882
  3. Baker, Dale

    1. You have access
      Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis
      Greg Coffey, Francis DeGuzman, Mayuko Inagaki, Yvonne Pak, Suzanne M. Delaney, Dan Ives, Andreas Betz, Zhaozhong J. Jia, Anjali Pandey, Dale Baker, Stanley J. Hollenbach, David R. Phillips and Uma Sinha
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 350-359; DOI: https://doi.org/10.1124/jpet.111.188441
  4. Beger, Richard

    1. You have access
      Changes in Mouse Liver Protein Glutathionylation after Acetaminophen Exposure
      Xi Yang, James Greenhaw, Akhtar Ali, Qiang Shi, Dean W. Roberts, Jack A. Hinson, Levan Muskhelishvili, Richard Beger, Lisa M. Pence, Yosuke Ando, Jinchun Sun, Kelly Davis and William F. Salminen
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 360-368; DOI: https://doi.org/10.1124/jpet.111.187948
  5. Benavidez, Jill M.

    1. You have access
      Behavioral Characterization of Knockin Mice with Mutations M287L and Q266I in the Glycine Receptor α1 Subunit
      Yuri A. Blednov, Jill M. Benavidez, Gregg E. Homanics and R. Adron Harris
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 317-329; DOI: https://doi.org/10.1124/jpet.111.185124
  6. Betz, Andreas

    1. You have access
      Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis
      Greg Coffey, Francis DeGuzman, Mayuko Inagaki, Yvonne Pak, Suzanne M. Delaney, Dan Ives, Andreas Betz, Zhaozhong J. Jia, Anjali Pandey, Dale Baker, Stanley J. Hollenbach, David R. Phillips and Uma Sinha
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 350-359; DOI: https://doi.org/10.1124/jpet.111.188441
  7. Blednov, Yuri A.

    1. You have access
      Behavioral Characterization of Knockin Mice with Mutations M287L and Q266I in the Glycine Receptor α1 Subunit
      Yuri A. Blednov, Jill M. Benavidez, Gregg E. Homanics and R. Adron Harris
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 317-329; DOI: https://doi.org/10.1124/jpet.111.185124
    2. You have access
      Characterization of Two Mutations, M287L and Q266I, in the α1 Glycine Receptor Subunit That Modify Sensitivity to Alcohols
      Cecilia M. Borghese, Yuri A. Blednov, Yu Quan, Sangeetha V. Iyer, Wei Xiong, S. John Mihic, Li Zhang, David M. Lovinger, James R. Trudell, Gregg E. Homanics and R. Adron Harris
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 304-316; DOI: https://doi.org/10.1124/jpet.111.185116
  8. Blobaum, Anna L.

    1. You have access
      The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease
      Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, Marianne Amalric, Anna L. Blobaum, Thomas M. Bridges, Ryan D. Morrison, Satyawan Jadhav, Darren W. Engers, Kimberly Italiano, Jacob Bode, J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, P. Jeffrey Conn and Colleen M. Niswender
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 404-421; DOI: https://doi.org/10.1124/jpet.111.187443
  9. Bode, Jacob

    1. You have access
      The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease
      Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, Marianne Amalric, Anna L. Blobaum, Thomas M. Bridges, Ryan D. Morrison, Satyawan Jadhav, Darren W. Engers, Kimberly Italiano, Jacob Bode, J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, P. Jeffrey Conn and Colleen M. Niswender
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 404-421; DOI: https://doi.org/10.1124/jpet.111.187443
  10. Borghese, Cecilia M.

    1. You have access
      Characterization of Two Mutations, M287L and Q266I, in the α1 Glycine Receptor Subunit That Modify Sensitivity to Alcohols
      Cecilia M. Borghese, Yuri A. Blednov, Yu Quan, Sangeetha V. Iyer, Wei Xiong, S. John Mihic, Li Zhang, David M. Lovinger, James R. Trudell, Gregg E. Homanics and R. Adron Harris
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 304-316; DOI: https://doi.org/10.1124/jpet.111.185116
  11. Bridges, Thomas M.

    1. You have access
      The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease
      Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, Marianne Amalric, Anna L. Blobaum, Thomas M. Bridges, Ryan D. Morrison, Satyawan Jadhav, Darren W. Engers, Kimberly Italiano, Jacob Bode, J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, P. Jeffrey Conn and Colleen M. Niswender
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 404-421; DOI: https://doi.org/10.1124/jpet.111.187443
  12. Brugger, Robin

    1. You have access
      Effects of the α2-Adrenergic Agonist Clonidine on the Pharmacodynamics and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Healthy Volunteers
      Cédric M. Hysek, Robin Brugger, Linda D. Simmler, Marcel Bruggisser, Massimiliano Donzelli, Eric Grouzmann, Marius C. Hoener and Matthias E. Liechti
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 286-294; DOI: https://doi.org/10.1124/jpet.111.188425
  13. Bruggisser, Marcel

    1. You have access
      Effects of the α2-Adrenergic Agonist Clonidine on the Pharmacodynamics and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Healthy Volunteers
      Cédric M. Hysek, Robin Brugger, Linda D. Simmler, Marcel Bruggisser, Massimiliano Donzelli, Eric Grouzmann, Marius C. Hoener and Matthias E. Liechti
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 286-294; DOI: https://doi.org/10.1124/jpet.111.188425
  14. Bubser, Michael

    1. You have access
      The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease
      Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, Marianne Amalric, Anna L. Blobaum, Thomas M. Bridges, Ryan D. Morrison, Satyawan Jadhav, Darren W. Engers, Kimberly Italiano, Jacob Bode, J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, P. Jeffrey Conn and Colleen M. Niswender
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 404-421; DOI: https://doi.org/10.1124/jpet.111.187443

C

  1. Cannone, Gianluigi

    1. You have access
      Structural Nucleotide Analogs Are Potent Activators/Inhibitors of Pancreatic β Cell KATP Channels: An Emerging Mechanism Supporting Their Use as Antidiabetic Drugs
      Domenico Tricarico, Jean-François Rolland, Gianluigi Cannone, Antonietta Mele, Valentina Cippone, Antonio Laghezza, Giuseppe Carbonara, Giuseppe Fracchiolla, Paolo Tortorella, Fulvio Loiodice and Diana Conte Camerino
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 266-276; DOI: https://doi.org/10.1124/jpet.111.185835
  2. Carbonara, Giuseppe

    1. You have access
      Structural Nucleotide Analogs Are Potent Activators/Inhibitors of Pancreatic β Cell KATP Channels: An Emerging Mechanism Supporting Their Use as Antidiabetic Drugs
      Domenico Tricarico, Jean-François Rolland, Gianluigi Cannone, Antonietta Mele, Valentina Cippone, Antonio Laghezza, Giuseppe Carbonara, Giuseppe Fracchiolla, Paolo Tortorella, Fulvio Loiodice and Diana Conte Camerino
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 266-276; DOI: https://doi.org/10.1124/jpet.111.185835
  3. Castro, Patricio A.

    1. You have access
      The Basic Property of Lys385 Is Important for Potentiation of the Human α1 Glycine Receptor by Ethanol
      Patricio A. Castro, Maximiliano Figueroa, Gonzalo E. Yevenes, Loreto S. San Martin and Luis G. Aguayo
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 339-349; DOI: https://doi.org/10.1124/jpet.111.185140
  4. Chaparro-Riggers, Javier

    1. You have access
      Proprotein Convertase Substilisin/Kexin Type 9 Antagonism Reduces Low-Density Lipoprotein Cholesterol in Statin-Treated Hypercholesterolemic Nonhuman Primates
      Hong Liang, Javier Chaparro-Riggers, Pavel Strop, Tao Geng, Janette E. Sutton, Daniel Tsai, Lanfang Bai, Yasmina Abdiche, Jeanette Dilley, Jessica Yu, Si Wu, S. Michael Chin, Nicole A. Lee, Andrea Rossi, John C. Lin, Arvind Rajpal, Jaume Pons and David L. Shelton
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 228-236; DOI: https://doi.org/10.1124/jpet.111.187419
  5. Cheng, Ka-Wing

    1. You have access
      Carboxylesterases 1 and 2 Hydrolyze Phospho-Nonsteroidal Anti-Inflammatory Drugs: Relevance to Their Pharmacological Activity
      Chi C. Wong, Ka-Wing Cheng, Gang Xie, Dingying Zhou, Cai-Hua Zhu, Panayiotis P. Constantinides and Basil Rigas
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 422-432; DOI: https://doi.org/10.1124/jpet.111.188508
  6. Chin, S. Michael

    1. You have access
      Proprotein Convertase Substilisin/Kexin Type 9 Antagonism Reduces Low-Density Lipoprotein Cholesterol in Statin-Treated Hypercholesterolemic Nonhuman Primates
      Hong Liang, Javier Chaparro-Riggers, Pavel Strop, Tao Geng, Janette E. Sutton, Daniel Tsai, Lanfang Bai, Yasmina Abdiche, Jeanette Dilley, Jessica Yu, Si Wu, S. Michael Chin, Nicole A. Lee, Andrea Rossi, John C. Lin, Arvind Rajpal, Jaume Pons and David L. Shelton
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 228-236; DOI: https://doi.org/10.1124/jpet.111.187419
  7. Chow, Chung-Wai

    1. You have access
      Spleen Tyrosine Kinase Mediates BEAS-2B Cell Migration and Proliferation and Human Rhinovirus-Induced Expression of Vascular Endothelial Growth Factor and Interleukin-8
      Xiaomin Wang, Mirek Mychajlowycz, Christine Lau, Carlos Gutierrez, Jeremy A. Scott and Chung-Wai Chow
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 277-285; DOI: https://doi.org/10.1124/jpet.111.186429
  8. Cippone, Valentina

    1. You have access
      Structural Nucleotide Analogs Are Potent Activators/Inhibitors of Pancreatic β Cell KATP Channels: An Emerging Mechanism Supporting Their Use as Antidiabetic Drugs
      Domenico Tricarico, Jean-François Rolland, Gianluigi Cannone, Antonietta Mele, Valentina Cippone, Antonio Laghezza, Giuseppe Carbonara, Giuseppe Fracchiolla, Paolo Tortorella, Fulvio Loiodice and Diana Conte Camerino
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 266-276; DOI: https://doi.org/10.1124/jpet.111.185835
  9. Coffey, Greg

    1. You have access
      Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis
      Greg Coffey, Francis DeGuzman, Mayuko Inagaki, Yvonne Pak, Suzanne M. Delaney, Dan Ives, Andreas Betz, Zhaozhong J. Jia, Anjali Pandey, Dale Baker, Stanley J. Hollenbach, David R. Phillips and Uma Sinha
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 350-359; DOI: https://doi.org/10.1124/jpet.111.188441
  10. Compadre, Cesar M.

    1. You have access
      γ-Tocotrienol Protects against Mitochondrial Dysfunction and Renal Cell Death
      Grażyna Nowak, Diana Bakajsova, Corey Hayes, Martin Hauer-Jensen and Cesar M. Compadre
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 330-338; DOI: https://doi.org/10.1124/jpet.111.186882
  11. Conn, P. Jeffrey

    1. You have access
      The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease
      Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, Marianne Amalric, Anna L. Blobaum, Thomas M. Bridges, Ryan D. Morrison, Satyawan Jadhav, Darren W. Engers, Kimberly Italiano, Jacob Bode, J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, P. Jeffrey Conn and Colleen M. Niswender
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 404-421; DOI: https://doi.org/10.1124/jpet.111.187443
  12. Constantinides, Panayiotis P.

    1. You have access
      Carboxylesterases 1 and 2 Hydrolyze Phospho-Nonsteroidal Anti-Inflammatory Drugs: Relevance to Their Pharmacological Activity
      Chi C. Wong, Ka-Wing Cheng, Gang Xie, Dingying Zhou, Cai-Hua Zhu, Panayiotis P. Constantinides and Basil Rigas
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 422-432; DOI: https://doi.org/10.1124/jpet.111.188508
  13. Conte Camerino, Diana

    1. You have access
      Structural Nucleotide Analogs Are Potent Activators/Inhibitors of Pancreatic β Cell KATP Channels: An Emerging Mechanism Supporting Their Use as Antidiabetic Drugs
      Domenico Tricarico, Jean-François Rolland, Gianluigi Cannone, Antonietta Mele, Valentina Cippone, Antonio Laghezza, Giuseppe Carbonara, Giuseppe Fracchiolla, Paolo Tortorella, Fulvio Loiodice and Diana Conte Camerino
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 266-276; DOI: https://doi.org/10.1124/jpet.111.185835
  14. Cotterell, Adam J.

    1. You have access
      Antagonism of Protease-Activated Receptor 2 Protects against Experimental Colitis
      Rink-Jan Lohman, Adam J. Cotterell, Jacky Suen, Ligong Liu, Anh T. Do, David A. Vesey and David P. Fairlie
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 256-265; DOI: https://doi.org/10.1124/jpet.111.187062

D

  1. Daniels, J. Scott

    1. You have access
      The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease
      Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, Marianne Amalric, Anna L. Blobaum, Thomas M. Bridges, Ryan D. Morrison, Satyawan Jadhav, Darren W. Engers, Kimberly Italiano, Jacob Bode, J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, P. Jeffrey Conn and Colleen M. Niswender
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 404-421; DOI: https://doi.org/10.1124/jpet.111.187443
  2. Davis, Kelly

    1. You have access
      Changes in Mouse Liver Protein Glutathionylation after Acetaminophen Exposure
      Xi Yang, James Greenhaw, Akhtar Ali, Qiang Shi, Dean W. Roberts, Jack A. Hinson, Levan Muskhelishvili, Richard Beger, Lisa M. Pence, Yosuke Ando, Jinchun Sun, Kelly Davis and William F. Salminen
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 360-368; DOI: https://doi.org/10.1124/jpet.111.187948
  3. DeGuzman, Francis

    1. You have access
      Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis
      Greg Coffey, Francis DeGuzman, Mayuko Inagaki, Yvonne Pak, Suzanne M. Delaney, Dan Ives, Andreas Betz, Zhaozhong J. Jia, Anjali Pandey, Dale Baker, Stanley J. Hollenbach, David R. Phillips and Uma Sinha
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 350-359; DOI: https://doi.org/10.1124/jpet.111.188441
  4. Delaney, Suzanne M.

    1. You have access
      Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis
      Greg Coffey, Francis DeGuzman, Mayuko Inagaki, Yvonne Pak, Suzanne M. Delaney, Dan Ives, Andreas Betz, Zhaozhong J. Jia, Anjali Pandey, Dale Baker, Stanley J. Hollenbach, David R. Phillips and Uma Sinha
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 350-359; DOI: https://doi.org/10.1124/jpet.111.188441
  5. Dickerson, Jonathan W.

    1. You have access
      The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease
      Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, Marianne Amalric, Anna L. Blobaum, Thomas M. Bridges, Ryan D. Morrison, Satyawan Jadhav, Darren W. Engers, Kimberly Italiano, Jacob Bode, J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, P. Jeffrey Conn and Colleen M. Niswender
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 404-421; DOI: https://doi.org/10.1124/jpet.111.187443
  6. Dilley, Jeanette

    1. You have access
      Proprotein Convertase Substilisin/Kexin Type 9 Antagonism Reduces Low-Density Lipoprotein Cholesterol in Statin-Treated Hypercholesterolemic Nonhuman Primates
      Hong Liang, Javier Chaparro-Riggers, Pavel Strop, Tao Geng, Janette E. Sutton, Daniel Tsai, Lanfang Bai, Yasmina Abdiche, Jeanette Dilley, Jessica Yu, Si Wu, S. Michael Chin, Nicole A. Lee, Andrea Rossi, John C. Lin, Arvind Rajpal, Jaume Pons and David L. Shelton
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 228-236; DOI: https://doi.org/10.1124/jpet.111.187419
  7. Do, Anh T.

    1. You have access
      Antagonism of Protease-Activated Receptor 2 Protects against Experimental Colitis
      Rink-Jan Lohman, Adam J. Cotterell, Jacky Suen, Ligong Liu, Anh T. Do, David A. Vesey and David P. Fairlie
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 256-265; DOI: https://doi.org/10.1124/jpet.111.187062
  8. Donzelli, Massimiliano

    1. You have access
      Effects of the α2-Adrenergic Agonist Clonidine on the Pharmacodynamics and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Healthy Volunteers
      Cédric M. Hysek, Robin Brugger, Linda D. Simmler, Marcel Bruggisser, Massimiliano Donzelli, Eric Grouzmann, Marius C. Hoener and Matthias E. Liechti
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 286-294; DOI: https://doi.org/10.1124/jpet.111.188425

E

  1. Ellis, Jonathan D.

    1. You have access
      Methamphetamine Self-Administration Causes Persistent Striatal Dopaminergic Alterations and Mitigates the Deficits Caused by a Subsequent Methamphetamine Exposure
      Lisa M. McFadden, Greg C. Hadlock, Scott C. Allen, Paula L. Vieira-Brock, Kristen A. Stout, Jonathan D. Ellis, Amanda J. Hoonakker, David M. Andrenyak, Shannon M. Nielsen, Diana G. Wilkins, Glen R. Hanson and Annette E. Fleckenstein
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 295-303; DOI: https://doi.org/10.1124/jpet.111.188433
  2. Elmslie, Keith S.

    1. You have access
      Roscovitine Inhibits CaV3.1 (T-Type) Channels by Preferentially Affecting Closed-State Inactivation
      Viktor Yarotskyy and Keith S. Elmslie
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 463-472; DOI: https://doi.org/10.1124/jpet.111.187104
  3. Engers, Darren W.

    1. You have access
      The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease
      Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, Marianne Amalric, Anna L. Blobaum, Thomas M. Bridges, Ryan D. Morrison, Satyawan Jadhav, Darren W. Engers, Kimberly Italiano, Jacob Bode, J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, P. Jeffrey Conn and Colleen M. Niswender
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 404-421; DOI: https://doi.org/10.1124/jpet.111.187443
  4. Enquist, Johan

    1. You have access
      Chronic Methadone Treatment Shows a Better Cost/Benefit Ratio than Chronic Morphine in Mice
      Johan Enquist, Madeline Ferwerda, Laura Milan-Lobo and Jennifer L. Whistler
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 386-392; DOI: https://doi.org/10.1124/jpet.111.187583

F

  1. Fairlie, David P.

    1. You have access
      Antagonism of Protease-Activated Receptor 2 Protects against Experimental Colitis
      Rink-Jan Lohman, Adam J. Cotterell, Jacky Suen, Ligong Liu, Anh T. Do, David A. Vesey and David P. Fairlie
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 256-265; DOI: https://doi.org/10.1124/jpet.111.187062
  2. Ferwerda, Madeline

    1. You have access
      Chronic Methadone Treatment Shows a Better Cost/Benefit Ratio than Chronic Morphine in Mice
      Johan Enquist, Madeline Ferwerda, Laura Milan-Lobo and Jennifer L. Whistler
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 386-392; DOI: https://doi.org/10.1124/jpet.111.187583
  3. Figueroa, Maximiliano

    1. You have access
      The Basic Property of Lys385 Is Important for Potentiation of the Human α1 Glycine Receptor by Ethanol
      Patricio A. Castro, Maximiliano Figueroa, Gonzalo E. Yevenes, Loreto S. San Martin and Luis G. Aguayo
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 339-349; DOI: https://doi.org/10.1124/jpet.111.185140
  4. Fleckenstein, Annette E.

    1. You have access
      Methamphetamine Self-Administration Causes Persistent Striatal Dopaminergic Alterations and Mitigates the Deficits Caused by a Subsequent Methamphetamine Exposure
      Lisa M. McFadden, Greg C. Hadlock, Scott C. Allen, Paula L. Vieira-Brock, Kristen A. Stout, Jonathan D. Ellis, Amanda J. Hoonakker, David M. Andrenyak, Shannon M. Nielsen, Diana G. Wilkins, Glen R. Hanson and Annette E. Fleckenstein
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 295-303; DOI: https://doi.org/10.1124/jpet.111.188433
  5. Fracchiolla, Giuseppe

    1. You have access
      Structural Nucleotide Analogs Are Potent Activators/Inhibitors of Pancreatic β Cell KATP Channels: An Emerging Mechanism Supporting Their Use as Antidiabetic Drugs
      Domenico Tricarico, Jean-François Rolland, Gianluigi Cannone, Antonietta Mele, Valentina Cippone, Antonio Laghezza, Giuseppe Carbonara, Giuseppe Fracchiolla, Paolo Tortorella, Fulvio Loiodice and Diana Conte Camerino
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 266-276; DOI: https://doi.org/10.1124/jpet.111.185835

G

  1. Gadthula, Srinivas

    1. You have access
      3-Substituted Pyrazole Analogs of the Cannabinoid Type 1 (CB1) Receptor Antagonist Rimonabant: Cannabinoid Agonist-Like Effects in Mice via Non-CB1, Non-CB2 Mechanism
      Jenny L. Wiley, Dana E. Selley, Pinglang Wang, Rudresha Kottani, Srinivas Gadthula and Anu Mahadeven
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 433-444; DOI: https://doi.org/10.1124/jpet.111.187815
  2. Gazi, Lucien

    1. You have access
      Pharmacologic Profile of OC000459, a Potent, Selective, and Orally Active D Prostanoid Receptor 2 Antagonist That Inhibits Mast Cell-Dependent Activation of T Helper 2 Lymphocytes and Eosinophils
      Roy Pettipher, Shân L. Vinall, Luzheng Xue, Graham Speight, Elizabeth R. Townsend, Lucien Gazi, Cliff J. Whelan, Richard E. Armer, Mark A. Payton and Michael G. Hunter
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 473-482; DOI: https://doi.org/10.1124/jpet.111.187203
  3. Geng, Tao

    1. You have access
      Proprotein Convertase Substilisin/Kexin Type 9 Antagonism Reduces Low-Density Lipoprotein Cholesterol in Statin-Treated Hypercholesterolemic Nonhuman Primates
      Hong Liang, Javier Chaparro-Riggers, Pavel Strop, Tao Geng, Janette E. Sutton, Daniel Tsai, Lanfang Bai, Yasmina Abdiche, Jeanette Dilley, Jessica Yu, Si Wu, S. Michael Chin, Nicole A. Lee, Andrea Rossi, John C. Lin, Arvind Rajpal, Jaume Pons and David L. Shelton
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 228-236; DOI: https://doi.org/10.1124/jpet.111.187419
  4. Glusa, Erika

    1. You have access
      Antiserotonergic Properties of Terguride in Blood Vessels, Platelets, and Valvular Interstitial Cells
      Alexandra Kekewska, Tilo Görnemann, Florian Jantschak, Erika Glusa and Heinz H. Pertz
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 369-376; DOI: https://doi.org/10.1124/jpet.111.187906
  5. Görnemann, Tilo

    1. You have access
      Antiserotonergic Properties of Terguride in Blood Vessels, Platelets, and Valvular Interstitial Cells
      Alexandra Kekewska, Tilo Görnemann, Florian Jantschak, Erika Glusa and Heinz H. Pertz
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 369-376; DOI: https://doi.org/10.1124/jpet.111.187906
  6. Greenhaw, James

    1. You have access
      Changes in Mouse Liver Protein Glutathionylation after Acetaminophen Exposure
      Xi Yang, James Greenhaw, Akhtar Ali, Qiang Shi, Dean W. Roberts, Jack A. Hinson, Levan Muskhelishvili, Richard Beger, Lisa M. Pence, Yosuke Ando, Jinchun Sun, Kelly Davis and William F. Salminen
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 360-368; DOI: https://doi.org/10.1124/jpet.111.187948
  7. Grouzmann, Eric

    1. You have access
      Effects of the α2-Adrenergic Agonist Clonidine on the Pharmacodynamics and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Healthy Volunteers
      Cédric M. Hysek, Robin Brugger, Linda D. Simmler, Marcel Bruggisser, Massimiliano Donzelli, Eric Grouzmann, Marius C. Hoener and Matthias E. Liechti
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 286-294; DOI: https://doi.org/10.1124/jpet.111.188425
  8. Gutierrez, Carlos

    1. You have access
      Spleen Tyrosine Kinase Mediates BEAS-2B Cell Migration and Proliferation and Human Rhinovirus-Induced Expression of Vascular Endothelial Growth Factor and Interleukin-8
      Xiaomin Wang, Mirek Mychajlowycz, Christine Lau, Carlos Gutierrez, Jeremy A. Scott and Chung-Wai Chow
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 277-285; DOI: https://doi.org/10.1124/jpet.111.186429

H

  1. Hadlock, Greg C.

    1. You have access
      Methamphetamine Self-Administration Causes Persistent Striatal Dopaminergic Alterations and Mitigates the Deficits Caused by a Subsequent Methamphetamine Exposure
      Lisa M. McFadden, Greg C. Hadlock, Scott C. Allen, Paula L. Vieira-Brock, Kristen A. Stout, Jonathan D. Ellis, Amanda J. Hoonakker, David M. Andrenyak, Shannon M. Nielsen, Diana G. Wilkins, Glen R. Hanson and Annette E. Fleckenstein
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 295-303; DOI: https://doi.org/10.1124/jpet.111.188433
  2. Hanson, Glen R.

    1. You have access
      Methamphetamine Self-Administration Causes Persistent Striatal Dopaminergic Alterations and Mitigates the Deficits Caused by a Subsequent Methamphetamine Exposure
      Lisa M. McFadden, Greg C. Hadlock, Scott C. Allen, Paula L. Vieira-Brock, Kristen A. Stout, Jonathan D. Ellis, Amanda J. Hoonakker, David M. Andrenyak, Shannon M. Nielsen, Diana G. Wilkins, Glen R. Hanson and Annette E. Fleckenstein
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 295-303; DOI: https://doi.org/10.1124/jpet.111.188433
  3. Harris, R. Adron

    1. You have access
      Behavioral Characterization of Knockin Mice with Mutations M287L and Q266I in the Glycine Receptor α1 Subunit
      Yuri A. Blednov, Jill M. Benavidez, Gregg E. Homanics and R. Adron Harris
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 317-329; DOI: https://doi.org/10.1124/jpet.111.185124
    2. You have access
      Characterization of Two Mutations, M287L and Q266I, in the α1 Glycine Receptor Subunit That Modify Sensitivity to Alcohols
      Cecilia M. Borghese, Yuri A. Blednov, Yu Quan, Sangeetha V. Iyer, Wei Xiong, S. John Mihic, Li Zhang, David M. Lovinger, James R. Trudell, Gregg E. Homanics and R. Adron Harris
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 304-316; DOI: https://doi.org/10.1124/jpet.111.185116
    3. You have access
      The TM2 6′ Position of GABAA Receptors Mediates Alcohol Inhibition
      W. David Johnson, Rebecca J. Howard, James R. Trudell and R. Adron Harris
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 445-456; DOI: https://doi.org/10.1124/jpet.111.188037
  4. Hauer-Jensen, Martin

    1. You have access
      γ-Tocotrienol Protects against Mitochondrial Dysfunction and Renal Cell Death
      Grażyna Nowak, Diana Bakajsova, Corey Hayes, Martin Hauer-Jensen and Cesar M. Compadre
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 330-338; DOI: https://doi.org/10.1124/jpet.111.186882
  5. Hayes, Corey

    1. You have access
      γ-Tocotrienol Protects against Mitochondrial Dysfunction and Renal Cell Death
      Grażyna Nowak, Diana Bakajsova, Corey Hayes, Martin Hauer-Jensen and Cesar M. Compadre
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 330-338; DOI: https://doi.org/10.1124/jpet.111.186882
  6. Hazama, Masatoshi

    1. You have access
      The Effects of TAK-875, a Selective G Protein-Coupled Receptor 40/Free Fatty Acid 1 Agonist, on Insulin and Glucagon Secretion in Isolated Rat and Human Islets
      Hiroaki Yashiro, Yoshiyuki Tsujihata, Koji Takeuchi, Masatoshi Hazama, Paul R. V. Johnson and Patrik Rorsman
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 483-489; DOI: https://doi.org/10.1124/jpet.111.187708
  7. Henry, Peter J.

    1. You have access
      Influence of Influenza A Infection on Capsaicin-Induced Responses in Murine Airways
      Samuel J. Taylor, Tracy S. Mann and Peter J. Henry
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 377-385; DOI: https://doi.org/10.1124/jpet.111.187872
  8. Hinson, Jack A.

    1. You have access
      Changes in Mouse Liver Protein Glutathionylation after Acetaminophen Exposure
      Xi Yang, James Greenhaw, Akhtar Ali, Qiang Shi, Dean W. Roberts, Jack A. Hinson, Levan Muskhelishvili, Richard Beger, Lisa M. Pence, Yosuke Ando, Jinchun Sun, Kelly Davis and William F. Salminen
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 360-368; DOI: https://doi.org/10.1124/jpet.111.187948
  9. Hoener, Marius C.

    1. You have access
      Effects of the α2-Adrenergic Agonist Clonidine on the Pharmacodynamics and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Healthy Volunteers
      Cédric M. Hysek, Robin Brugger, Linda D. Simmler, Marcel Bruggisser, Massimiliano Donzelli, Eric Grouzmann, Marius C. Hoener and Matthias E. Liechti
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 286-294; DOI: https://doi.org/10.1124/jpet.111.188425
  10. Hollenbach, Stanley J.

    1. You have access
      Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis
      Greg Coffey, Francis DeGuzman, Mayuko Inagaki, Yvonne Pak, Suzanne M. Delaney, Dan Ives, Andreas Betz, Zhaozhong J. Jia, Anjali Pandey, Dale Baker, Stanley J. Hollenbach, David R. Phillips and Uma Sinha
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 350-359; DOI: https://doi.org/10.1124/jpet.111.188441
  11. Homanics, Gregg E.

    1. You have access
      Behavioral Characterization of Knockin Mice with Mutations M287L and Q266I in the Glycine Receptor α1 Subunit
      Yuri A. Blednov, Jill M. Benavidez, Gregg E. Homanics and R. Adron Harris
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 317-329; DOI: https://doi.org/10.1124/jpet.111.185124
    2. You have access
      Characterization of Two Mutations, M287L and Q266I, in the α1 Glycine Receptor Subunit That Modify Sensitivity to Alcohols
      Cecilia M. Borghese, Yuri A. Blednov, Yu Quan, Sangeetha V. Iyer, Wei Xiong, S. John Mihic, Li Zhang, David M. Lovinger, James R. Trudell, Gregg E. Homanics and R. Adron Harris
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 304-316; DOI: https://doi.org/10.1124/jpet.111.185116
  12. Hoonakker, Amanda J.

    1. You have access
      Methamphetamine Self-Administration Causes Persistent Striatal Dopaminergic Alterations and Mitigates the Deficits Caused by a Subsequent Methamphetamine Exposure
      Lisa M. McFadden, Greg C. Hadlock, Scott C. Allen, Paula L. Vieira-Brock, Kristen A. Stout, Jonathan D. Ellis, Amanda J. Hoonakker, David M. Andrenyak, Shannon M. Nielsen, Diana G. Wilkins, Glen R. Hanson and Annette E. Fleckenstein
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 295-303; DOI: https://doi.org/10.1124/jpet.111.188433
  13. Hopkins, Corey R.

    1. You have access
      The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease
      Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, Marianne Amalric, Anna L. Blobaum, Thomas M. Bridges, Ryan D. Morrison, Satyawan Jadhav, Darren W. Engers, Kimberly Italiano, Jacob Bode, J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, P. Jeffrey Conn and Colleen M. Niswender
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 404-421; DOI: https://doi.org/10.1124/jpet.111.187443
  14. Howard, Rebecca J.

    1. You have access
      The TM2 6′ Position of GABAA Receptors Mediates Alcohol Inhibition
      W. David Johnson, Rebecca J. Howard, James R. Trudell and R. Adron Harris
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 445-456; DOI: https://doi.org/10.1124/jpet.111.188037
  15. Hunter, Michael G.

    1. You have access
      Pharmacologic Profile of OC000459, a Potent, Selective, and Orally Active D Prostanoid Receptor 2 Antagonist That Inhibits Mast Cell-Dependent Activation of T Helper 2 Lymphocytes and Eosinophils
      Roy Pettipher, Shân L. Vinall, Luzheng Xue, Graham Speight, Elizabeth R. Townsend, Lucien Gazi, Cliff J. Whelan, Richard E. Armer, Mark A. Payton and Michael G. Hunter
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 473-482; DOI: https://doi.org/10.1124/jpet.111.187203
  16. Hysek, Cédric M.

    1. You have access
      Effects of the α2-Adrenergic Agonist Clonidine on the Pharmacodynamics and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Healthy Volunteers
      Cédric M. Hysek, Robin Brugger, Linda D. Simmler, Marcel Bruggisser, Massimiliano Donzelli, Eric Grouzmann, Marius C. Hoener and Matthias E. Liechti
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 286-294; DOI: https://doi.org/10.1124/jpet.111.188425

I

  1. Inagaki, Mayuko

    1. You have access
      Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis
      Greg Coffey, Francis DeGuzman, Mayuko Inagaki, Yvonne Pak, Suzanne M. Delaney, Dan Ives, Andreas Betz, Zhaozhong J. Jia, Anjali Pandey, Dale Baker, Stanley J. Hollenbach, David R. Phillips and Uma Sinha
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 350-359; DOI: https://doi.org/10.1124/jpet.111.188441
  2. Inoue, Katsuhisa

    1. You have access
      Competitive Inhibition of the Luminal Efflux by Multidrug and Toxin Extrusions, but Not Basolateral Uptake by Organic Cation Transporter 2, Is the Likely Mechanism Underlying the Pharmacokinetic Drug-Drug Interactions Caused by Cimetidine in the Kidney
      Sumito Ito, Hiroyuki Kusuhara, Miyu Yokochi, Junko Toyoshima, Katsuhisa Inoue, Hiroaki Yuasa and Yuichi Sugiyama
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 393-403; DOI: https://doi.org/10.1124/jpet.111.184986
  3. Italiano, Kimberly

    1. You have access
      The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease
      Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, Marianne Amalric, Anna L. Blobaum, Thomas M. Bridges, Ryan D. Morrison, Satyawan Jadhav, Darren W. Engers, Kimberly Italiano, Jacob Bode, J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, P. Jeffrey Conn and Colleen M. Niswender
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 404-421; DOI: https://doi.org/10.1124/jpet.111.187443
  4. Ito, Sumito

    1. You have access
      Competitive Inhibition of the Luminal Efflux by Multidrug and Toxin Extrusions, but Not Basolateral Uptake by Organic Cation Transporter 2, Is the Likely Mechanism Underlying the Pharmacokinetic Drug-Drug Interactions Caused by Cimetidine in the Kidney
      Sumito Ito, Hiroyuki Kusuhara, Miyu Yokochi, Junko Toyoshima, Katsuhisa Inoue, Hiroaki Yuasa and Yuichi Sugiyama
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 393-403; DOI: https://doi.org/10.1124/jpet.111.184986
  5. Ives, Dan

    1. You have access
      Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis
      Greg Coffey, Francis DeGuzman, Mayuko Inagaki, Yvonne Pak, Suzanne M. Delaney, Dan Ives, Andreas Betz, Zhaozhong J. Jia, Anjali Pandey, Dale Baker, Stanley J. Hollenbach, David R. Phillips and Uma Sinha
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 350-359; DOI: https://doi.org/10.1124/jpet.111.188441
  6. Iyer, Sangeetha V.

    1. You have access
      Characterization of Two Mutations, M287L and Q266I, in the α1 Glycine Receptor Subunit That Modify Sensitivity to Alcohols
      Cecilia M. Borghese, Yuri A. Blednov, Yu Quan, Sangeetha V. Iyer, Wei Xiong, S. John Mihic, Li Zhang, David M. Lovinger, James R. Trudell, Gregg E. Homanics and R. Adron Harris
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 304-316; DOI: https://doi.org/10.1124/jpet.111.185116

J

  1. Jadhav, Satyawan

    1. You have access
      The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease
      Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, Marianne Amalric, Anna L. Blobaum, Thomas M. Bridges, Ryan D. Morrison, Satyawan Jadhav, Darren W. Engers, Kimberly Italiano, Jacob Bode, J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, P. Jeffrey Conn and Colleen M. Niswender
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 404-421; DOI: https://doi.org/10.1124/jpet.111.187443
  2. James, Taryn T.

    1. You have access
      Histone H3 Phosphorylation (Ser10, Ser28) and Phosphoacetylation (K9S10) Are Differentially Associated with Gene Expression in Liver of Rats Treated In Vivo with Acute Ethanol
      Taryn T. James, Annayya R. Aroor, Robert W. Lim and Shivendra D. Shukla
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 237-247; DOI: https://doi.org/10.1124/jpet.111.186775
  3. Jantschak, Florian

    1. You have access
      Antiserotonergic Properties of Terguride in Blood Vessels, Platelets, and Valvular Interstitial Cells
      Alexandra Kekewska, Tilo Görnemann, Florian Jantschak, Erika Glusa and Heinz H. Pertz
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 369-376; DOI: https://doi.org/10.1124/jpet.111.187906
  4. Jia, Zhaozhong J.

    1. You have access
      Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis
      Greg Coffey, Francis DeGuzman, Mayuko Inagaki, Yvonne Pak, Suzanne M. Delaney, Dan Ives, Andreas Betz, Zhaozhong J. Jia, Anjali Pandey, Dale Baker, Stanley J. Hollenbach, David R. Phillips and Uma Sinha
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 350-359; DOI: https://doi.org/10.1124/jpet.111.188441
  5. Jin, Heung Yong

    1. You have access
      Dipeptidyl Peptidase IV Inhibitor Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats
      Wei Jing Liu, Shu Hua Xie, Yu Ning Liu, Won Kim, Heung Yong Jin, Sung Kwang Park, Yi Ming Shao and Tae Sun Park
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 248-255; DOI: https://doi.org/10.1124/jpet.111.186866
  6. Johnson, Paul R. V.

    1. You have access
      The Effects of TAK-875, a Selective G Protein-Coupled Receptor 40/Free Fatty Acid 1 Agonist, on Insulin and Glucagon Secretion in Isolated Rat and Human Islets
      Hiroaki Yashiro, Yoshiyuki Tsujihata, Koji Takeuchi, Masatoshi Hazama, Paul R. V. Johnson and Patrik Rorsman
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 483-489; DOI: https://doi.org/10.1124/jpet.111.187708
  7. Johnson, W. David

    1. You have access
      The TM2 6′ Position of GABAA Receptors Mediates Alcohol Inhibition
      W. David Johnson, Rebecca J. Howard, James R. Trudell and R. Adron Harris
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 445-456; DOI: https://doi.org/10.1124/jpet.111.188037
  8. Jones, Carrie K.

    1. You have access
      The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease
      Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, Marianne Amalric, Anna L. Blobaum, Thomas M. Bridges, Ryan D. Morrison, Satyawan Jadhav, Darren W. Engers, Kimberly Italiano, Jacob Bode, J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, P. Jeffrey Conn and Colleen M. Niswender
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 404-421; DOI: https://doi.org/10.1124/jpet.111.187443

K

  1. Kekewska, Alexandra

    1. You have access
      Antiserotonergic Properties of Terguride in Blood Vessels, Platelets, and Valvular Interstitial Cells
      Alexandra Kekewska, Tilo Görnemann, Florian Jantschak, Erika Glusa and Heinz H. Pertz
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 369-376; DOI: https://doi.org/10.1124/jpet.111.187906
  2. Kim, Won

    1. You have access
      Dipeptidyl Peptidase IV Inhibitor Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats
      Wei Jing Liu, Shu Hua Xie, Yu Ning Liu, Won Kim, Heung Yong Jin, Sung Kwang Park, Yi Ming Shao and Tae Sun Park
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 248-255; DOI: https://doi.org/10.1124/jpet.111.186866
  3. Komuro, Masahito

    1. You have access
      Involvement of Concentrative Nucleoside Transporter 1 in Intestinal Absorption of Trifluorothymidine, a Novel Antitumor Nucleoside, in Rats
      Takashige Okayama, Kunihiro Yoshisue, Keizo Kuwata, Masahito Komuro, Shigeru Ohta and Sekio Nagayama
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 457-462; DOI: https://doi.org/10.1124/jpet.111.186296
  4. Kottani, Rudresha

    1. You have access
      3-Substituted Pyrazole Analogs of the Cannabinoid Type 1 (CB1) Receptor Antagonist Rimonabant: Cannabinoid Agonist-Like Effects in Mice via Non-CB1, Non-CB2 Mechanism
      Jenny L. Wiley, Dana E. Selley, Pinglang Wang, Rudresha Kottani, Srinivas Gadthula and Anu Mahadeven
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 433-444; DOI: https://doi.org/10.1124/jpet.111.187815
  5. Kusuhara, Hiroyuki

    1. You have access
      Competitive Inhibition of the Luminal Efflux by Multidrug and Toxin Extrusions, but Not Basolateral Uptake by Organic Cation Transporter 2, Is the Likely Mechanism Underlying the Pharmacokinetic Drug-Drug Interactions Caused by Cimetidine in the Kidney
      Sumito Ito, Hiroyuki Kusuhara, Miyu Yokochi, Junko Toyoshima, Katsuhisa Inoue, Hiroaki Yuasa and Yuichi Sugiyama
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 393-403; DOI: https://doi.org/10.1124/jpet.111.184986
  6. Kuwata, Keizo

    1. You have access
      Involvement of Concentrative Nucleoside Transporter 1 in Intestinal Absorption of Trifluorothymidine, a Novel Antitumor Nucleoside, in Rats
      Takashige Okayama, Kunihiro Yoshisue, Keizo Kuwata, Masahito Komuro, Shigeru Ohta and Sekio Nagayama
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 457-462; DOI: https://doi.org/10.1124/jpet.111.186296

L

  1. Laghezza, Antonio

    1. You have access
      Structural Nucleotide Analogs Are Potent Activators/Inhibitors of Pancreatic β Cell KATP Channels: An Emerging Mechanism Supporting Their Use as Antidiabetic Drugs
      Domenico Tricarico, Jean-François Rolland, Gianluigi Cannone, Antonietta Mele, Valentina Cippone, Antonio Laghezza, Giuseppe Carbonara, Giuseppe Fracchiolla, Paolo Tortorella, Fulvio Loiodice and Diana Conte Camerino
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 266-276; DOI: https://doi.org/10.1124/jpet.111.185835
  2. Lau, Christine

    1. You have access
      Spleen Tyrosine Kinase Mediates BEAS-2B Cell Migration and Proliferation and Human Rhinovirus-Induced Expression of Vascular Endothelial Growth Factor and Interleukin-8
      Xiaomin Wang, Mirek Mychajlowycz, Christine Lau, Carlos Gutierrez, Jeremy A. Scott and Chung-Wai Chow
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 277-285; DOI: https://doi.org/10.1124/jpet.111.186429
  3. Lee, Nicole A.

    1. You have access
      Proprotein Convertase Substilisin/Kexin Type 9 Antagonism Reduces Low-Density Lipoprotein Cholesterol in Statin-Treated Hypercholesterolemic Nonhuman Primates
      Hong Liang, Javier Chaparro-Riggers, Pavel Strop, Tao Geng, Janette E. Sutton, Daniel Tsai, Lanfang Bai, Yasmina Abdiche, Jeanette Dilley, Jessica Yu, Si Wu, S. Michael Chin, Nicole A. Lee, Andrea Rossi, John C. Lin, Arvind Rajpal, Jaume Pons and David L. Shelton
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 228-236; DOI: https://doi.org/10.1124/jpet.111.187419
  4. Liang, Hong

    1. You have access
      Proprotein Convertase Substilisin/Kexin Type 9 Antagonism Reduces Low-Density Lipoprotein Cholesterol in Statin-Treated Hypercholesterolemic Nonhuman Primates
      Hong Liang, Javier Chaparro-Riggers, Pavel Strop, Tao Geng, Janette E. Sutton, Daniel Tsai, Lanfang Bai, Yasmina Abdiche, Jeanette Dilley, Jessica Yu, Si Wu, S. Michael Chin, Nicole A. Lee, Andrea Rossi, John C. Lin, Arvind Rajpal, Jaume Pons and David L. Shelton
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 228-236; DOI: https://doi.org/10.1124/jpet.111.187419
  5. Liechti, Matthias E.

    1. You have access
      Effects of the α2-Adrenergic Agonist Clonidine on the Pharmacodynamics and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Healthy Volunteers
      Cédric M. Hysek, Robin Brugger, Linda D. Simmler, Marcel Bruggisser, Massimiliano Donzelli, Eric Grouzmann, Marius C. Hoener and Matthias E. Liechti
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 286-294; DOI: https://doi.org/10.1124/jpet.111.188425
  6. Lim, Robert W.

    1. You have access
      Histone H3 Phosphorylation (Ser10, Ser28) and Phosphoacetylation (K9S10) Are Differentially Associated with Gene Expression in Liver of Rats Treated In Vivo with Acute Ethanol
      Taryn T. James, Annayya R. Aroor, Robert W. Lim and Shivendra D. Shukla
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 237-247; DOI: https://doi.org/10.1124/jpet.111.186775
  7. Lin, John C.

    1. You have access
      Proprotein Convertase Substilisin/Kexin Type 9 Antagonism Reduces Low-Density Lipoprotein Cholesterol in Statin-Treated Hypercholesterolemic Nonhuman Primates
      Hong Liang, Javier Chaparro-Riggers, Pavel Strop, Tao Geng, Janette E. Sutton, Daniel Tsai, Lanfang Bai, Yasmina Abdiche, Jeanette Dilley, Jessica Yu, Si Wu, S. Michael Chin, Nicole A. Lee, Andrea Rossi, John C. Lin, Arvind Rajpal, Jaume Pons and David L. Shelton
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 228-236; DOI: https://doi.org/10.1124/jpet.111.187419
  8. Lindsley, Craig W.

    1. You have access
      The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease
      Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, Marianne Amalric, Anna L. Blobaum, Thomas M. Bridges, Ryan D. Morrison, Satyawan Jadhav, Darren W. Engers, Kimberly Italiano, Jacob Bode, J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, P. Jeffrey Conn and Colleen M. Niswender
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 404-421; DOI: https://doi.org/10.1124/jpet.111.187443
  9. Liu, Ligong

    1. You have access
      Antagonism of Protease-Activated Receptor 2 Protects against Experimental Colitis
      Rink-Jan Lohman, Adam J. Cotterell, Jacky Suen, Ligong Liu, Anh T. Do, David A. Vesey and David P. Fairlie
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 256-265; DOI: https://doi.org/10.1124/jpet.111.187062
  10. Liu, Wei Jing

    1. You have access
      Dipeptidyl Peptidase IV Inhibitor Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats
      Wei Jing Liu, Shu Hua Xie, Yu Ning Liu, Won Kim, Heung Yong Jin, Sung Kwang Park, Yi Ming Shao and Tae Sun Park
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 248-255; DOI: https://doi.org/10.1124/jpet.111.186866
  11. Liu, Yu Ning

    1. You have access
      Dipeptidyl Peptidase IV Inhibitor Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats
      Wei Jing Liu, Shu Hua Xie, Yu Ning Liu, Won Kim, Heung Yong Jin, Sung Kwang Park, Yi Ming Shao and Tae Sun Park
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 248-255; DOI: https://doi.org/10.1124/jpet.111.186866
  12. Lohman, Rink-Jan

    1. You have access
      Antagonism of Protease-Activated Receptor 2 Protects against Experimental Colitis
      Rink-Jan Lohman, Adam J. Cotterell, Jacky Suen, Ligong Liu, Anh T. Do, David A. Vesey and David P. Fairlie
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 256-265; DOI: https://doi.org/10.1124/jpet.111.187062
  13. Loiodice, Fulvio

    1. You have access
      Structural Nucleotide Analogs Are Potent Activators/Inhibitors of Pancreatic β Cell KATP Channels: An Emerging Mechanism Supporting Their Use as Antidiabetic Drugs
      Domenico Tricarico, Jean-François Rolland, Gianluigi Cannone, Antonietta Mele, Valentina Cippone, Antonio Laghezza, Giuseppe Carbonara, Giuseppe Fracchiolla, Paolo Tortorella, Fulvio Loiodice and Diana Conte Camerino
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 266-276; DOI: https://doi.org/10.1124/jpet.111.185835
  14. Lovinger, David M.

    1. You have access
      Characterization of Two Mutations, M287L and Q266I, in the α1 Glycine Receptor Subunit That Modify Sensitivity to Alcohols
      Cecilia M. Borghese, Yuri A. Blednov, Yu Quan, Sangeetha V. Iyer, Wei Xiong, S. John Mihic, Li Zhang, David M. Lovinger, James R. Trudell, Gregg E. Homanics and R. Adron Harris
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 304-316; DOI: https://doi.org/10.1124/jpet.111.185116

M

  1. Mahadeven, Anu

    1. You have access
      3-Substituted Pyrazole Analogs of the Cannabinoid Type 1 (CB1) Receptor Antagonist Rimonabant: Cannabinoid Agonist-Like Effects in Mice via Non-CB1, Non-CB2 Mechanism
      Jenny L. Wiley, Dana E. Selley, Pinglang Wang, Rudresha Kottani, Srinivas Gadthula and Anu Mahadeven
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 433-444; DOI: https://doi.org/10.1124/jpet.111.187815
  2. Mann, Tracy S.

    1. You have access
      Influence of Influenza A Infection on Capsaicin-Induced Responses in Murine Airways
      Samuel J. Taylor, Tracy S. Mann and Peter J. Henry
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 377-385; DOI: https://doi.org/10.1124/jpet.111.187872
  3. McFadden, Lisa M.

    1. You have access
      Methamphetamine Self-Administration Causes Persistent Striatal Dopaminergic Alterations and Mitigates the Deficits Caused by a Subsequent Methamphetamine Exposure
      Lisa M. McFadden, Greg C. Hadlock, Scott C. Allen, Paula L. Vieira-Brock, Kristen A. Stout, Jonathan D. Ellis, Amanda J. Hoonakker, David M. Andrenyak, Shannon M. Nielsen, Diana G. Wilkins, Glen R. Hanson and Annette E. Fleckenstein
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 295-303; DOI: https://doi.org/10.1124/jpet.111.188433
  4. Mele, Antonietta

    1. You have access
      Structural Nucleotide Analogs Are Potent Activators/Inhibitors of Pancreatic β Cell KATP Channels: An Emerging Mechanism Supporting Their Use as Antidiabetic Drugs
      Domenico Tricarico, Jean-François Rolland, Gianluigi Cannone, Antonietta Mele, Valentina Cippone, Antonio Laghezza, Giuseppe Carbonara, Giuseppe Fracchiolla, Paolo Tortorella, Fulvio Loiodice and Diana Conte Camerino
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 266-276; DOI: https://doi.org/10.1124/jpet.111.185835
  5. Mihic, S. John

    1. You have access
      Characterization of Two Mutations, M287L and Q266I, in the α1 Glycine Receptor Subunit That Modify Sensitivity to Alcohols
      Cecilia M. Borghese, Yuri A. Blednov, Yu Quan, Sangeetha V. Iyer, Wei Xiong, S. John Mihic, Li Zhang, David M. Lovinger, James R. Trudell, Gregg E. Homanics and R. Adron Harris
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 304-316; DOI: https://doi.org/10.1124/jpet.111.185116
  6. Milan-Lobo, Laura

    1. You have access
      Chronic Methadone Treatment Shows a Better Cost/Benefit Ratio than Chronic Morphine in Mice
      Johan Enquist, Madeline Ferwerda, Laura Milan-Lobo and Jennifer L. Whistler
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 386-392; DOI: https://doi.org/10.1124/jpet.111.187583
  7. Morrison, Ryan D.

    1. You have access
      The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease
      Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, Marianne Amalric, Anna L. Blobaum, Thomas M. Bridges, Ryan D. Morrison, Satyawan Jadhav, Darren W. Engers, Kimberly Italiano, Jacob Bode, J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, P. Jeffrey Conn and Colleen M. Niswender
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 404-421; DOI: https://doi.org/10.1124/jpet.111.187443
  8. Muskhelishvili, Levan

    1. You have access
      Changes in Mouse Liver Protein Glutathionylation after Acetaminophen Exposure
      Xi Yang, James Greenhaw, Akhtar Ali, Qiang Shi, Dean W. Roberts, Jack A. Hinson, Levan Muskhelishvili, Richard Beger, Lisa M. Pence, Yosuke Ando, Jinchun Sun, Kelly Davis and William F. Salminen
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 360-368; DOI: https://doi.org/10.1124/jpet.111.187948
  9. Mychajlowycz, Mirek

    1. You have access
      Spleen Tyrosine Kinase Mediates BEAS-2B Cell Migration and Proliferation and Human Rhinovirus-Induced Expression of Vascular Endothelial Growth Factor and Interleukin-8
      Xiaomin Wang, Mirek Mychajlowycz, Christine Lau, Carlos Gutierrez, Jeremy A. Scott and Chung-Wai Chow
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 277-285; DOI: https://doi.org/10.1124/jpet.111.186429

N

  1. Nagayama, Sekio

    1. You have access
      Involvement of Concentrative Nucleoside Transporter 1 in Intestinal Absorption of Trifluorothymidine, a Novel Antitumor Nucleoside, in Rats
      Takashige Okayama, Kunihiro Yoshisue, Keizo Kuwata, Masahito Komuro, Shigeru Ohta and Sekio Nagayama
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 457-462; DOI: https://doi.org/10.1124/jpet.111.186296
  2. Nielsen, Shannon M.

    1. You have access
      Methamphetamine Self-Administration Causes Persistent Striatal Dopaminergic Alterations and Mitigates the Deficits Caused by a Subsequent Methamphetamine Exposure
      Lisa M. McFadden, Greg C. Hadlock, Scott C. Allen, Paula L. Vieira-Brock, Kristen A. Stout, Jonathan D. Ellis, Amanda J. Hoonakker, David M. Andrenyak, Shannon M. Nielsen, Diana G. Wilkins, Glen R. Hanson and Annette E. Fleckenstein
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 295-303; DOI: https://doi.org/10.1124/jpet.111.188433
  3. Niswender, Colleen M.

    1. You have access
      The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease
      Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, Marianne Amalric, Anna L. Blobaum, Thomas M. Bridges, Ryan D. Morrison, Satyawan Jadhav, Darren W. Engers, Kimberly Italiano, Jacob Bode, J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, P. Jeffrey Conn and Colleen M. Niswender
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 404-421; DOI: https://doi.org/10.1124/jpet.111.187443
  4. Nowak, Grażyna

    1. You have access
      γ-Tocotrienol Protects against Mitochondrial Dysfunction and Renal Cell Death
      Grażyna Nowak, Diana Bakajsova, Corey Hayes, Martin Hauer-Jensen and Cesar M. Compadre
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 330-338; DOI: https://doi.org/10.1124/jpet.111.186882

O

  1. Ohta, Shigeru

    1. You have access
      Involvement of Concentrative Nucleoside Transporter 1 in Intestinal Absorption of Trifluorothymidine, a Novel Antitumor Nucleoside, in Rats
      Takashige Okayama, Kunihiro Yoshisue, Keizo Kuwata, Masahito Komuro, Shigeru Ohta and Sekio Nagayama
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 457-462; DOI: https://doi.org/10.1124/jpet.111.186296
  2. Okayama, Takashige

    1. You have access
      Involvement of Concentrative Nucleoside Transporter 1 in Intestinal Absorption of Trifluorothymidine, a Novel Antitumor Nucleoside, in Rats
      Takashige Okayama, Kunihiro Yoshisue, Keizo Kuwata, Masahito Komuro, Shigeru Ohta and Sekio Nagayama
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 457-462; DOI: https://doi.org/10.1124/jpet.111.186296

P

  1. Pak, Yvonne

    1. You have access
      Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis
      Greg Coffey, Francis DeGuzman, Mayuko Inagaki, Yvonne Pak, Suzanne M. Delaney, Dan Ives, Andreas Betz, Zhaozhong J. Jia, Anjali Pandey, Dale Baker, Stanley J. Hollenbach, David R. Phillips and Uma Sinha
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 350-359; DOI: https://doi.org/10.1124/jpet.111.188441
  2. Pandey, Anjali

    1. You have access
      Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis
      Greg Coffey, Francis DeGuzman, Mayuko Inagaki, Yvonne Pak, Suzanne M. Delaney, Dan Ives, Andreas Betz, Zhaozhong J. Jia, Anjali Pandey, Dale Baker, Stanley J. Hollenbach, David R. Phillips and Uma Sinha
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 350-359; DOI: https://doi.org/10.1124/jpet.111.188441
  3. Park, Sung Kwang

    1. You have access
      Dipeptidyl Peptidase IV Inhibitor Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats
      Wei Jing Liu, Shu Hua Xie, Yu Ning Liu, Won Kim, Heung Yong Jin, Sung Kwang Park, Yi Ming Shao and Tae Sun Park
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 248-255; DOI: https://doi.org/10.1124/jpet.111.186866
  4. Park, Tae Sun

    1. You have access
      Dipeptidyl Peptidase IV Inhibitor Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats
      Wei Jing Liu, Shu Hua Xie, Yu Ning Liu, Won Kim, Heung Yong Jin, Sung Kwang Park, Yi Ming Shao and Tae Sun Park
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 248-255; DOI: https://doi.org/10.1124/jpet.111.186866
  5. Payton, Mark A.

    1. You have access
      Pharmacologic Profile of OC000459, a Potent, Selective, and Orally Active D Prostanoid Receptor 2 Antagonist That Inhibits Mast Cell-Dependent Activation of T Helper 2 Lymphocytes and Eosinophils
      Roy Pettipher, Shân L. Vinall, Luzheng Xue, Graham Speight, Elizabeth R. Townsend, Lucien Gazi, Cliff J. Whelan, Richard E. Armer, Mark A. Payton and Michael G. Hunter
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 473-482; DOI: https://doi.org/10.1124/jpet.111.187203
  6. Pence, Lisa M.

    1. You have access
      Changes in Mouse Liver Protein Glutathionylation after Acetaminophen Exposure
      Xi Yang, James Greenhaw, Akhtar Ali, Qiang Shi, Dean W. Roberts, Jack A. Hinson, Levan Muskhelishvili, Richard Beger, Lisa M. Pence, Yosuke Ando, Jinchun Sun, Kelly Davis and William F. Salminen
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 360-368; DOI: https://doi.org/10.1124/jpet.111.187948
  7. Pertz, Heinz H.

    1. You have access
      Antiserotonergic Properties of Terguride in Blood Vessels, Platelets, and Valvular Interstitial Cells
      Alexandra Kekewska, Tilo Görnemann, Florian Jantschak, Erika Glusa and Heinz H. Pertz
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 369-376; DOI: https://doi.org/10.1124/jpet.111.187906
  8. Pettipher, Roy

    1. You have access
      Pharmacologic Profile of OC000459, a Potent, Selective, and Orally Active D Prostanoid Receptor 2 Antagonist That Inhibits Mast Cell-Dependent Activation of T Helper 2 Lymphocytes and Eosinophils
      Roy Pettipher, Shân L. Vinall, Luzheng Xue, Graham Speight, Elizabeth R. Townsend, Lucien Gazi, Cliff J. Whelan, Richard E. Armer, Mark A. Payton and Michael G. Hunter
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 473-482; DOI: https://doi.org/10.1124/jpet.111.187203
  9. Phillips, David R.

    1. You have access
      Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis
      Greg Coffey, Francis DeGuzman, Mayuko Inagaki, Yvonne Pak, Suzanne M. Delaney, Dan Ives, Andreas Betz, Zhaozhong J. Jia, Anjali Pandey, Dale Baker, Stanley J. Hollenbach, David R. Phillips and Uma Sinha
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 350-359; DOI: https://doi.org/10.1124/jpet.111.188441
  10. Pons, Jaume

    1. You have access
      Proprotein Convertase Substilisin/Kexin Type 9 Antagonism Reduces Low-Density Lipoprotein Cholesterol in Statin-Treated Hypercholesterolemic Nonhuman Primates
      Hong Liang, Javier Chaparro-Riggers, Pavel Strop, Tao Geng, Janette E. Sutton, Daniel Tsai, Lanfang Bai, Yasmina Abdiche, Jeanette Dilley, Jessica Yu, Si Wu, S. Michael Chin, Nicole A. Lee, Andrea Rossi, John C. Lin, Arvind Rajpal, Jaume Pons and David L. Shelton
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 228-236; DOI: https://doi.org/10.1124/jpet.111.187419

Q

  1. Quan, Yu

    1. You have access
      Characterization of Two Mutations, M287L and Q266I, in the α1 Glycine Receptor Subunit That Modify Sensitivity to Alcohols
      Cecilia M. Borghese, Yuri A. Blednov, Yu Quan, Sangeetha V. Iyer, Wei Xiong, S. John Mihic, Li Zhang, David M. Lovinger, James R. Trudell, Gregg E. Homanics and R. Adron Harris
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 304-316; DOI: https://doi.org/10.1124/jpet.111.185116

R

  1. Rajpal, Arvind

    1. You have access
      Proprotein Convertase Substilisin/Kexin Type 9 Antagonism Reduces Low-Density Lipoprotein Cholesterol in Statin-Treated Hypercholesterolemic Nonhuman Primates
      Hong Liang, Javier Chaparro-Riggers, Pavel Strop, Tao Geng, Janette E. Sutton, Daniel Tsai, Lanfang Bai, Yasmina Abdiche, Jeanette Dilley, Jessica Yu, Si Wu, S. Michael Chin, Nicole A. Lee, Andrea Rossi, John C. Lin, Arvind Rajpal, Jaume Pons and David L. Shelton
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 228-236; DOI: https://doi.org/10.1124/jpet.111.187419
  2. Rigas, Basil

    1. You have access
      Carboxylesterases 1 and 2 Hydrolyze Phospho-Nonsteroidal Anti-Inflammatory Drugs: Relevance to Their Pharmacological Activity
      Chi C. Wong, Ka-Wing Cheng, Gang Xie, Dingying Zhou, Cai-Hua Zhu, Panayiotis P. Constantinides and Basil Rigas
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 422-432; DOI: https://doi.org/10.1124/jpet.111.188508
  3. Roberts, Dean W.

    1. You have access
      Changes in Mouse Liver Protein Glutathionylation after Acetaminophen Exposure
      Xi Yang, James Greenhaw, Akhtar Ali, Qiang Shi, Dean W. Roberts, Jack A. Hinson, Levan Muskhelishvili, Richard Beger, Lisa M. Pence, Yosuke Ando, Jinchun Sun, Kelly Davis and William F. Salminen
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 360-368; DOI: https://doi.org/10.1124/jpet.111.187948
  4. Rolland, Jean-François

    1. You have access
      Structural Nucleotide Analogs Are Potent Activators/Inhibitors of Pancreatic β Cell KATP Channels: An Emerging Mechanism Supporting Their Use as Antidiabetic Drugs
      Domenico Tricarico, Jean-François Rolland, Gianluigi Cannone, Antonietta Mele, Valentina Cippone, Antonio Laghezza, Giuseppe Carbonara, Giuseppe Fracchiolla, Paolo Tortorella, Fulvio Loiodice and Diana Conte Camerino
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 266-276; DOI: https://doi.org/10.1124/jpet.111.185835
  5. Rorsman, Patrik

    1. You have access
      The Effects of TAK-875, a Selective G Protein-Coupled Receptor 40/Free Fatty Acid 1 Agonist, on Insulin and Glucagon Secretion in Isolated Rat and Human Islets
      Hiroaki Yashiro, Yoshiyuki Tsujihata, Koji Takeuchi, Masatoshi Hazama, Paul R. V. Johnson and Patrik Rorsman
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 483-489; DOI: https://doi.org/10.1124/jpet.111.187708
  6. Rossi, Andrea

    1. You have access
      Proprotein Convertase Substilisin/Kexin Type 9 Antagonism Reduces Low-Density Lipoprotein Cholesterol in Statin-Treated Hypercholesterolemic Nonhuman Primates
      Hong Liang, Javier Chaparro-Riggers, Pavel Strop, Tao Geng, Janette E. Sutton, Daniel Tsai, Lanfang Bai, Yasmina Abdiche, Jeanette Dilley, Jessica Yu, Si Wu, S. Michael Chin, Nicole A. Lee, Andrea Rossi, John C. Lin, Arvind Rajpal, Jaume Pons and David L. Shelton
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 228-236; DOI: https://doi.org/10.1124/jpet.111.187419

S

  1. Salminen, William F.

    1. You have access
      Changes in Mouse Liver Protein Glutathionylation after Acetaminophen Exposure
      Xi Yang, James Greenhaw, Akhtar Ali, Qiang Shi, Dean W. Roberts, Jack A. Hinson, Levan Muskhelishvili, Richard Beger, Lisa M. Pence, Yosuke Ando, Jinchun Sun, Kelly Davis and William F. Salminen
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 360-368; DOI: https://doi.org/10.1124/jpet.111.187948
  2. San Martin, Loreto S.

    1. You have access
      The Basic Property of Lys385 Is Important for Potentiation of the Human α1 Glycine Receptor by Ethanol
      Patricio A. Castro, Maximiliano Figueroa, Gonzalo E. Yevenes, Loreto S. San Martin and Luis G. Aguayo
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 339-349; DOI: https://doi.org/10.1124/jpet.111.185140
  3. Scott, Jeremy A.

    1. You have access
      Spleen Tyrosine Kinase Mediates BEAS-2B Cell Migration and Proliferation and Human Rhinovirus-Induced Expression of Vascular Endothelial Growth Factor and Interleukin-8
      Xiaomin Wang, Mirek Mychajlowycz, Christine Lau, Carlos Gutierrez, Jeremy A. Scott and Chung-Wai Chow
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 277-285; DOI: https://doi.org/10.1124/jpet.111.186429
  4. Selley, Dana E.

    1. You have access
      3-Substituted Pyrazole Analogs of the Cannabinoid Type 1 (CB1) Receptor Antagonist Rimonabant: Cannabinoid Agonist-Like Effects in Mice via Non-CB1, Non-CB2 Mechanism
      Jenny L. Wiley, Dana E. Selley, Pinglang Wang, Rudresha Kottani, Srinivas Gadthula and Anu Mahadeven
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 433-444; DOI: https://doi.org/10.1124/jpet.111.187815
  5. Shao, Yi Ming

    1. You have access
      Dipeptidyl Peptidase IV Inhibitor Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats
      Wei Jing Liu, Shu Hua Xie, Yu Ning Liu, Won Kim, Heung Yong Jin, Sung Kwang Park, Yi Ming Shao and Tae Sun Park
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 248-255; DOI: https://doi.org/10.1124/jpet.111.186866
  6. Shelton, David L.

    1. You have access
      Proprotein Convertase Substilisin/Kexin Type 9 Antagonism Reduces Low-Density Lipoprotein Cholesterol in Statin-Treated Hypercholesterolemic Nonhuman Primates
      Hong Liang, Javier Chaparro-Riggers, Pavel Strop, Tao Geng, Janette E. Sutton, Daniel Tsai, Lanfang Bai, Yasmina Abdiche, Jeanette Dilley, Jessica Yu, Si Wu, S. Michael Chin, Nicole A. Lee, Andrea Rossi, John C. Lin, Arvind Rajpal, Jaume Pons and David L. Shelton
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 228-236; DOI: https://doi.org/10.1124/jpet.111.187419
  7. Shi, Qiang

    1. You have access
      Changes in Mouse Liver Protein Glutathionylation after Acetaminophen Exposure
      Xi Yang, James Greenhaw, Akhtar Ali, Qiang Shi, Dean W. Roberts, Jack A. Hinson, Levan Muskhelishvili, Richard Beger, Lisa M. Pence, Yosuke Ando, Jinchun Sun, Kelly Davis and William F. Salminen
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 360-368; DOI: https://doi.org/10.1124/jpet.111.187948
  8. Shukla, Shivendra D.

    1. You have access
      Histone H3 Phosphorylation (Ser10, Ser28) and Phosphoacetylation (K9S10) Are Differentially Associated with Gene Expression in Liver of Rats Treated In Vivo with Acute Ethanol
      Taryn T. James, Annayya R. Aroor, Robert W. Lim and Shivendra D. Shukla
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 237-247; DOI: https://doi.org/10.1124/jpet.111.186775
  9. Simmler, Linda D.

    1. You have access
      Effects of the α2-Adrenergic Agonist Clonidine on the Pharmacodynamics and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Healthy Volunteers
      Cédric M. Hysek, Robin Brugger, Linda D. Simmler, Marcel Bruggisser, Massimiliano Donzelli, Eric Grouzmann, Marius C. Hoener and Matthias E. Liechti
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 286-294; DOI: https://doi.org/10.1124/jpet.111.188425
  10. Sinha, Uma

    1. You have access
      Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis
      Greg Coffey, Francis DeGuzman, Mayuko Inagaki, Yvonne Pak, Suzanne M. Delaney, Dan Ives, Andreas Betz, Zhaozhong J. Jia, Anjali Pandey, Dale Baker, Stanley J. Hollenbach, David R. Phillips and Uma Sinha
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 350-359; DOI: https://doi.org/10.1124/jpet.111.188441
  11. Speight, Graham

    1. You have access
      Pharmacologic Profile of OC000459, a Potent, Selective, and Orally Active D Prostanoid Receptor 2 Antagonist That Inhibits Mast Cell-Dependent Activation of T Helper 2 Lymphocytes and Eosinophils
      Roy Pettipher, Shân L. Vinall, Luzheng Xue, Graham Speight, Elizabeth R. Townsend, Lucien Gazi, Cliff J. Whelan, Richard E. Armer, Mark A. Payton and Michael G. Hunter
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 473-482; DOI: https://doi.org/10.1124/jpet.111.187203
  12. Stout, Kristen A.

    1. You have access
      Methamphetamine Self-Administration Causes Persistent Striatal Dopaminergic Alterations and Mitigates the Deficits Caused by a Subsequent Methamphetamine Exposure
      Lisa M. McFadden, Greg C. Hadlock, Scott C. Allen, Paula L. Vieira-Brock, Kristen A. Stout, Jonathan D. Ellis, Amanda J. Hoonakker, David M. Andrenyak, Shannon M. Nielsen, Diana G. Wilkins, Glen R. Hanson and Annette E. Fleckenstein
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 295-303; DOI: https://doi.org/10.1124/jpet.111.188433
  13. Strop, Pavel

    1. You have access
      Proprotein Convertase Substilisin/Kexin Type 9 Antagonism Reduces Low-Density Lipoprotein Cholesterol in Statin-Treated Hypercholesterolemic Nonhuman Primates
      Hong Liang, Javier Chaparro-Riggers, Pavel Strop, Tao Geng, Janette E. Sutton, Daniel Tsai, Lanfang Bai, Yasmina Abdiche, Jeanette Dilley, Jessica Yu, Si Wu, S. Michael Chin, Nicole A. Lee, Andrea Rossi, John C. Lin, Arvind Rajpal, Jaume Pons and David L. Shelton
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 228-236; DOI: https://doi.org/10.1124/jpet.111.187419
  14. Suen, Jacky

    1. You have access
      Antagonism of Protease-Activated Receptor 2 Protects against Experimental Colitis
      Rink-Jan Lohman, Adam J. Cotterell, Jacky Suen, Ligong Liu, Anh T. Do, David A. Vesey and David P. Fairlie
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 256-265; DOI: https://doi.org/10.1124/jpet.111.187062
  15. Sugiyama, Yuichi

    1. You have access
      Competitive Inhibition of the Luminal Efflux by Multidrug and Toxin Extrusions, but Not Basolateral Uptake by Organic Cation Transporter 2, Is the Likely Mechanism Underlying the Pharmacokinetic Drug-Drug Interactions Caused by Cimetidine in the Kidney
      Sumito Ito, Hiroyuki Kusuhara, Miyu Yokochi, Junko Toyoshima, Katsuhisa Inoue, Hiroaki Yuasa and Yuichi Sugiyama
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 393-403; DOI: https://doi.org/10.1124/jpet.111.184986
  16. Sun, Jinchun

    1. You have access
      Changes in Mouse Liver Protein Glutathionylation after Acetaminophen Exposure
      Xi Yang, James Greenhaw, Akhtar Ali, Qiang Shi, Dean W. Roberts, Jack A. Hinson, Levan Muskhelishvili, Richard Beger, Lisa M. Pence, Yosuke Ando, Jinchun Sun, Kelly Davis and William F. Salminen
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 360-368; DOI: https://doi.org/10.1124/jpet.111.187948
  17. Sutton, Janette E.

    1. You have access
      Proprotein Convertase Substilisin/Kexin Type 9 Antagonism Reduces Low-Density Lipoprotein Cholesterol in Statin-Treated Hypercholesterolemic Nonhuman Primates
      Hong Liang, Javier Chaparro-Riggers, Pavel Strop, Tao Geng, Janette E. Sutton, Daniel Tsai, Lanfang Bai, Yasmina Abdiche, Jeanette Dilley, Jessica Yu, Si Wu, S. Michael Chin, Nicole A. Lee, Andrea Rossi, John C. Lin, Arvind Rajpal, Jaume Pons and David L. Shelton
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 228-236; DOI: https://doi.org/10.1124/jpet.111.187419

T

  1. Takeuchi, Koji

    1. You have access
      The Effects of TAK-875, a Selective G Protein-Coupled Receptor 40/Free Fatty Acid 1 Agonist, on Insulin and Glucagon Secretion in Isolated Rat and Human Islets
      Hiroaki Yashiro, Yoshiyuki Tsujihata, Koji Takeuchi, Masatoshi Hazama, Paul R. V. Johnson and Patrik Rorsman
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 483-489; DOI: https://doi.org/10.1124/jpet.111.187708
  2. Taylor, Samuel J.

    1. You have access
      Influence of Influenza A Infection on Capsaicin-Induced Responses in Murine Airways
      Samuel J. Taylor, Tracy S. Mann and Peter J. Henry
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 377-385; DOI: https://doi.org/10.1124/jpet.111.187872
  3. Thompson, Analisa D.

    1. You have access
      The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease
      Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, Marianne Amalric, Anna L. Blobaum, Thomas M. Bridges, Ryan D. Morrison, Satyawan Jadhav, Darren W. Engers, Kimberly Italiano, Jacob Bode, J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, P. Jeffrey Conn and Colleen M. Niswender
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 404-421; DOI: https://doi.org/10.1124/jpet.111.187443
  4. Tortorella, Paolo

    1. You have access
      Structural Nucleotide Analogs Are Potent Activators/Inhibitors of Pancreatic β Cell KATP Channels: An Emerging Mechanism Supporting Their Use as Antidiabetic Drugs
      Domenico Tricarico, Jean-François Rolland, Gianluigi Cannone, Antonietta Mele, Valentina Cippone, Antonio Laghezza, Giuseppe Carbonara, Giuseppe Fracchiolla, Paolo Tortorella, Fulvio Loiodice and Diana Conte Camerino
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 266-276; DOI: https://doi.org/10.1124/jpet.111.185835
  5. Townsend, Elizabeth R.

    1. You have access
      Pharmacologic Profile of OC000459, a Potent, Selective, and Orally Active D Prostanoid Receptor 2 Antagonist That Inhibits Mast Cell-Dependent Activation of T Helper 2 Lymphocytes and Eosinophils
      Roy Pettipher, Shân L. Vinall, Luzheng Xue, Graham Speight, Elizabeth R. Townsend, Lucien Gazi, Cliff J. Whelan, Richard E. Armer, Mark A. Payton and Michael G. Hunter
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 473-482; DOI: https://doi.org/10.1124/jpet.111.187203
  6. Toyoshima, Junko

    1. You have access
      Competitive Inhibition of the Luminal Efflux by Multidrug and Toxin Extrusions, but Not Basolateral Uptake by Organic Cation Transporter 2, Is the Likely Mechanism Underlying the Pharmacokinetic Drug-Drug Interactions Caused by Cimetidine in the Kidney
      Sumito Ito, Hiroyuki Kusuhara, Miyu Yokochi, Junko Toyoshima, Katsuhisa Inoue, Hiroaki Yuasa and Yuichi Sugiyama
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 393-403; DOI: https://doi.org/10.1124/jpet.111.184986
  7. Tricarico, Domenico

    1. You have access
      Structural Nucleotide Analogs Are Potent Activators/Inhibitors of Pancreatic β Cell KATP Channels: An Emerging Mechanism Supporting Their Use as Antidiabetic Drugs
      Domenico Tricarico, Jean-François Rolland, Gianluigi Cannone, Antonietta Mele, Valentina Cippone, Antonio Laghezza, Giuseppe Carbonara, Giuseppe Fracchiolla, Paolo Tortorella, Fulvio Loiodice and Diana Conte Camerino
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 266-276; DOI: https://doi.org/10.1124/jpet.111.185835
  8. Trudell, James R.

    1. You have access
      Characterization of Two Mutations, M287L and Q266I, in the α1 Glycine Receptor Subunit That Modify Sensitivity to Alcohols
      Cecilia M. Borghese, Yuri A. Blednov, Yu Quan, Sangeetha V. Iyer, Wei Xiong, S. John Mihic, Li Zhang, David M. Lovinger, James R. Trudell, Gregg E. Homanics and R. Adron Harris
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 304-316; DOI: https://doi.org/10.1124/jpet.111.185116
    2. You have access
      The TM2 6′ Position of GABAA Receptors Mediates Alcohol Inhibition
      W. David Johnson, Rebecca J. Howard, James R. Trudell and R. Adron Harris
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 445-456; DOI: https://doi.org/10.1124/jpet.111.188037
  9. Tsai, Daniel

    1. You have access
      Proprotein Convertase Substilisin/Kexin Type 9 Antagonism Reduces Low-Density Lipoprotein Cholesterol in Statin-Treated Hypercholesterolemic Nonhuman Primates
      Hong Liang, Javier Chaparro-Riggers, Pavel Strop, Tao Geng, Janette E. Sutton, Daniel Tsai, Lanfang Bai, Yasmina Abdiche, Jeanette Dilley, Jessica Yu, Si Wu, S. Michael Chin, Nicole A. Lee, Andrea Rossi, John C. Lin, Arvind Rajpal, Jaume Pons and David L. Shelton
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 228-236; DOI: https://doi.org/10.1124/jpet.111.187419
  10. Tsujihata, Yoshiyuki

    1. You have access
      The Effects of TAK-875, a Selective G Protein-Coupled Receptor 40/Free Fatty Acid 1 Agonist, on Insulin and Glucagon Secretion in Isolated Rat and Human Islets
      Hiroaki Yashiro, Yoshiyuki Tsujihata, Koji Takeuchi, Masatoshi Hazama, Paul R. V. Johnson and Patrik Rorsman
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 483-489; DOI: https://doi.org/10.1124/jpet.111.187708
  11. Turle-Lorenzo, Nathalie

    1. You have access
      The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease
      Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, Marianne Amalric, Anna L. Blobaum, Thomas M. Bridges, Ryan D. Morrison, Satyawan Jadhav, Darren W. Engers, Kimberly Italiano, Jacob Bode, J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, P. Jeffrey Conn and Colleen M. Niswender
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 404-421; DOI: https://doi.org/10.1124/jpet.111.187443

V

  1. Vesey, David A.

    1. You have access
      Antagonism of Protease-Activated Receptor 2 Protects against Experimental Colitis
      Rink-Jan Lohman, Adam J. Cotterell, Jacky Suen, Ligong Liu, Anh T. Do, David A. Vesey and David P. Fairlie
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 256-265; DOI: https://doi.org/10.1124/jpet.111.187062
  2. Vieira-Brock, Paula L.

    1. You have access
      Methamphetamine Self-Administration Causes Persistent Striatal Dopaminergic Alterations and Mitigates the Deficits Caused by a Subsequent Methamphetamine Exposure
      Lisa M. McFadden, Greg C. Hadlock, Scott C. Allen, Paula L. Vieira-Brock, Kristen A. Stout, Jonathan D. Ellis, Amanda J. Hoonakker, David M. Andrenyak, Shannon M. Nielsen, Diana G. Wilkins, Glen R. Hanson and Annette E. Fleckenstein
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 295-303; DOI: https://doi.org/10.1124/jpet.111.188433
  3. Vinall, Shân L.

    1. You have access
      Pharmacologic Profile of OC000459, a Potent, Selective, and Orally Active D Prostanoid Receptor 2 Antagonist That Inhibits Mast Cell-Dependent Activation of T Helper 2 Lymphocytes and Eosinophils
      Roy Pettipher, Shân L. Vinall, Luzheng Xue, Graham Speight, Elizabeth R. Townsend, Lucien Gazi, Cliff J. Whelan, Richard E. Armer, Mark A. Payton and Michael G. Hunter
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 473-482; DOI: https://doi.org/10.1124/jpet.111.187203

W

  1. Wang, Pinglang

    1. You have access
      3-Substituted Pyrazole Analogs of the Cannabinoid Type 1 (CB1) Receptor Antagonist Rimonabant: Cannabinoid Agonist-Like Effects in Mice via Non-CB1, Non-CB2 Mechanism
      Jenny L. Wiley, Dana E. Selley, Pinglang Wang, Rudresha Kottani, Srinivas Gadthula and Anu Mahadeven
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 433-444; DOI: https://doi.org/10.1124/jpet.111.187815
  2. Wang, Xiaomin

    1. You have access
      Spleen Tyrosine Kinase Mediates BEAS-2B Cell Migration and Proliferation and Human Rhinovirus-Induced Expression of Vascular Endothelial Growth Factor and Interleukin-8
      Xiaomin Wang, Mirek Mychajlowycz, Christine Lau, Carlos Gutierrez, Jeremy A. Scott and Chung-Wai Chow
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 277-285; DOI: https://doi.org/10.1124/jpet.111.186429
  3. Whelan, Cliff J.

    1. You have access
      Pharmacologic Profile of OC000459, a Potent, Selective, and Orally Active D Prostanoid Receptor 2 Antagonist That Inhibits Mast Cell-Dependent Activation of T Helper 2 Lymphocytes and Eosinophils
      Roy Pettipher, Shân L. Vinall, Luzheng Xue, Graham Speight, Elizabeth R. Townsend, Lucien Gazi, Cliff J. Whelan, Richard E. Armer, Mark A. Payton and Michael G. Hunter
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 473-482; DOI: https://doi.org/10.1124/jpet.111.187203
  4. Whistler, Jennifer L.

    1. You have access
      Chronic Methadone Treatment Shows a Better Cost/Benefit Ratio than Chronic Morphine in Mice
      Johan Enquist, Madeline Ferwerda, Laura Milan-Lobo and Jennifer L. Whistler
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 386-392; DOI: https://doi.org/10.1124/jpet.111.187583
  5. Wiley, Jenny L.

    1. You have access
      3-Substituted Pyrazole Analogs of the Cannabinoid Type 1 (CB1) Receptor Antagonist Rimonabant: Cannabinoid Agonist-Like Effects in Mice via Non-CB1, Non-CB2 Mechanism
      Jenny L. Wiley, Dana E. Selley, Pinglang Wang, Rudresha Kottani, Srinivas Gadthula and Anu Mahadeven
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 433-444; DOI: https://doi.org/10.1124/jpet.111.187815
  6. Wilkins, Diana G.

    1. You have access
      Methamphetamine Self-Administration Causes Persistent Striatal Dopaminergic Alterations and Mitigates the Deficits Caused by a Subsequent Methamphetamine Exposure
      Lisa M. McFadden, Greg C. Hadlock, Scott C. Allen, Paula L. Vieira-Brock, Kristen A. Stout, Jonathan D. Ellis, Amanda J. Hoonakker, David M. Andrenyak, Shannon M. Nielsen, Diana G. Wilkins, Glen R. Hanson and Annette E. Fleckenstein
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 295-303; DOI: https://doi.org/10.1124/jpet.111.188433
  7. Wong, Chi C.

    1. You have access
      Carboxylesterases 1 and 2 Hydrolyze Phospho-Nonsteroidal Anti-Inflammatory Drugs: Relevance to Their Pharmacological Activity
      Chi C. Wong, Ka-Wing Cheng, Gang Xie, Dingying Zhou, Cai-Hua Zhu, Panayiotis P. Constantinides and Basil Rigas
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 422-432; DOI: https://doi.org/10.1124/jpet.111.188508
  8. Wu, Si

    1. You have access
      Proprotein Convertase Substilisin/Kexin Type 9 Antagonism Reduces Low-Density Lipoprotein Cholesterol in Statin-Treated Hypercholesterolemic Nonhuman Primates
      Hong Liang, Javier Chaparro-Riggers, Pavel Strop, Tao Geng, Janette E. Sutton, Daniel Tsai, Lanfang Bai, Yasmina Abdiche, Jeanette Dilley, Jessica Yu, Si Wu, S. Michael Chin, Nicole A. Lee, Andrea Rossi, John C. Lin, Arvind Rajpal, Jaume Pons and David L. Shelton
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 228-236; DOI: https://doi.org/10.1124/jpet.111.187419

X

  1. Xie, Gang

    1. You have access
      Carboxylesterases 1 and 2 Hydrolyze Phospho-Nonsteroidal Anti-Inflammatory Drugs: Relevance to Their Pharmacological Activity
      Chi C. Wong, Ka-Wing Cheng, Gang Xie, Dingying Zhou, Cai-Hua Zhu, Panayiotis P. Constantinides and Basil Rigas
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 422-432; DOI: https://doi.org/10.1124/jpet.111.188508
  2. Xie, Shu Hua

    1. You have access
      Dipeptidyl Peptidase IV Inhibitor Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats
      Wei Jing Liu, Shu Hua Xie, Yu Ning Liu, Won Kim, Heung Yong Jin, Sung Kwang Park, Yi Ming Shao and Tae Sun Park
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 248-255; DOI: https://doi.org/10.1124/jpet.111.186866
  3. Xiong, Wei

    1. You have access
      Characterization of Two Mutations, M287L and Q266I, in the α1 Glycine Receptor Subunit That Modify Sensitivity to Alcohols
      Cecilia M. Borghese, Yuri A. Blednov, Yu Quan, Sangeetha V. Iyer, Wei Xiong, S. John Mihic, Li Zhang, David M. Lovinger, James R. Trudell, Gregg E. Homanics and R. Adron Harris
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 304-316; DOI: https://doi.org/10.1124/jpet.111.185116
  4. Xue, Luzheng

    1. You have access
      Pharmacologic Profile of OC000459, a Potent, Selective, and Orally Active D Prostanoid Receptor 2 Antagonist That Inhibits Mast Cell-Dependent Activation of T Helper 2 Lymphocytes and Eosinophils
      Roy Pettipher, Shân L. Vinall, Luzheng Xue, Graham Speight, Elizabeth R. Townsend, Lucien Gazi, Cliff J. Whelan, Richard E. Armer, Mark A. Payton and Michael G. Hunter
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 473-482; DOI: https://doi.org/10.1124/jpet.111.187203

Y

  1. Yang, Xi

    1. You have access
      Changes in Mouse Liver Protein Glutathionylation after Acetaminophen Exposure
      Xi Yang, James Greenhaw, Akhtar Ali, Qiang Shi, Dean W. Roberts, Jack A. Hinson, Levan Muskhelishvili, Richard Beger, Lisa M. Pence, Yosuke Ando, Jinchun Sun, Kelly Davis and William F. Salminen
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 360-368; DOI: https://doi.org/10.1124/jpet.111.187948
  2. Yarotskyy, Viktor

    1. You have access
      Roscovitine Inhibits CaV3.1 (T-Type) Channels by Preferentially Affecting Closed-State Inactivation
      Viktor Yarotskyy and Keith S. Elmslie
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 463-472; DOI: https://doi.org/10.1124/jpet.111.187104
  3. Yashiro, Hiroaki

    1. You have access
      The Effects of TAK-875, a Selective G Protein-Coupled Receptor 40/Free Fatty Acid 1 Agonist, on Insulin and Glucagon Secretion in Isolated Rat and Human Islets
      Hiroaki Yashiro, Yoshiyuki Tsujihata, Koji Takeuchi, Masatoshi Hazama, Paul R. V. Johnson and Patrik Rorsman
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 483-489; DOI: https://doi.org/10.1124/jpet.111.187708
  4. Yevenes, Gonzalo E.

    1. You have access
      The Basic Property of Lys385 Is Important for Potentiation of the Human α1 Glycine Receptor by Ethanol
      Patricio A. Castro, Maximiliano Figueroa, Gonzalo E. Yevenes, Loreto S. San Martin and Luis G. Aguayo
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 339-349; DOI: https://doi.org/10.1124/jpet.111.185140
  5. Yokochi, Miyu

    1. You have access
      Competitive Inhibition of the Luminal Efflux by Multidrug and Toxin Extrusions, but Not Basolateral Uptake by Organic Cation Transporter 2, Is the Likely Mechanism Underlying the Pharmacokinetic Drug-Drug Interactions Caused by Cimetidine in the Kidney
      Sumito Ito, Hiroyuki Kusuhara, Miyu Yokochi, Junko Toyoshima, Katsuhisa Inoue, Hiroaki Yuasa and Yuichi Sugiyama
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 393-403; DOI: https://doi.org/10.1124/jpet.111.184986
  6. Yoshisue, Kunihiro

    1. You have access
      Involvement of Concentrative Nucleoside Transporter 1 in Intestinal Absorption of Trifluorothymidine, a Novel Antitumor Nucleoside, in Rats
      Takashige Okayama, Kunihiro Yoshisue, Keizo Kuwata, Masahito Komuro, Shigeru Ohta and Sekio Nagayama
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 457-462; DOI: https://doi.org/10.1124/jpet.111.186296
  7. Yu, Jessica

    1. You have access
      Proprotein Convertase Substilisin/Kexin Type 9 Antagonism Reduces Low-Density Lipoprotein Cholesterol in Statin-Treated Hypercholesterolemic Nonhuman Primates
      Hong Liang, Javier Chaparro-Riggers, Pavel Strop, Tao Geng, Janette E. Sutton, Daniel Tsai, Lanfang Bai, Yasmina Abdiche, Jeanette Dilley, Jessica Yu, Si Wu, S. Michael Chin, Nicole A. Lee, Andrea Rossi, John C. Lin, Arvind Rajpal, Jaume Pons and David L. Shelton
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 228-236; DOI: https://doi.org/10.1124/jpet.111.187419
  8. Yuasa, Hiroaki

    1. You have access
      Competitive Inhibition of the Luminal Efflux by Multidrug and Toxin Extrusions, but Not Basolateral Uptake by Organic Cation Transporter 2, Is the Likely Mechanism Underlying the Pharmacokinetic Drug-Drug Interactions Caused by Cimetidine in the Kidney
      Sumito Ito, Hiroyuki Kusuhara, Miyu Yokochi, Junko Toyoshima, Katsuhisa Inoue, Hiroaki Yuasa and Yuichi Sugiyama
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 393-403; DOI: https://doi.org/10.1124/jpet.111.184986

Z

  1. Zhang, Li

    1. You have access
      Characterization of Two Mutations, M287L and Q266I, in the α1 Glycine Receptor Subunit That Modify Sensitivity to Alcohols
      Cecilia M. Borghese, Yuri A. Blednov, Yu Quan, Sangeetha V. Iyer, Wei Xiong, S. John Mihic, Li Zhang, David M. Lovinger, James R. Trudell, Gregg E. Homanics and R. Adron Harris
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 304-316; DOI: https://doi.org/10.1124/jpet.111.185116
  2. Zhou, Dingying

    1. You have access
      Carboxylesterases 1 and 2 Hydrolyze Phospho-Nonsteroidal Anti-Inflammatory Drugs: Relevance to Their Pharmacological Activity
      Chi C. Wong, Ka-Wing Cheng, Gang Xie, Dingying Zhou, Cai-Hua Zhu, Panayiotis P. Constantinides and Basil Rigas
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 422-432; DOI: https://doi.org/10.1124/jpet.111.188508
  3. Zhu, Cai-Hua

    1. You have access
      Carboxylesterases 1 and 2 Hydrolyze Phospho-Nonsteroidal Anti-Inflammatory Drugs: Relevance to Their Pharmacological Activity
      Chi C. Wong, Ka-Wing Cheng, Gang Xie, Dingying Zhou, Cai-Hua Zhu, Panayiotis P. Constantinides and Basil Rigas
      Journal of Pharmacology and Experimental Therapeutics February 2012, 340 (2) 422-432; DOI: https://doi.org/10.1124/jpet.111.188508
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 340 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 340, Issue 2
1 Feb 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics